Doximity (NYSE:DOCS – Get Free Report)‘s stock had its “underperform” rating reaffirmed by Bank of America in a research note issued on Monday,Benzinga reports. They currently have a $20.00 price target on the stock, down from their previous price target of $38.00. Bank of America‘s price objective suggests a potential downside of 3.88% from the company’s current price.
Several other research firms also recently commented on DOCS. Freedom Capital upgraded shares of Doximity to a “strong-buy” rating in a research note on Tuesday, March 17th. Barclays reiterated an “equal weight” rating and issued a $20.00 price objective (down from $38.00) on shares of Doximity in a research note on Thursday, May 14th. Evercore lowered Doximity from an “outperform” rating to an “in-line” rating and set a $25.00 target price for the company. in a report on Wednesday, April 8th. KeyCorp cut Doximity from an “overweight” rating to a “sector weight” rating in a research note on Thursday, May 14th. Finally, Citigroup downgraded Doximity to an “underperform” rating in a report on Monday. Two equities research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, twelve have issued a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat, Doximity currently has an average rating of “Hold” and a consensus price target of $29.33.
View Our Latest Research Report on DOCS
Doximity Stock Performance
Insider Buying and Selling at Doximity
In other news, insider Siddharth Sitaram sold 2,444 shares of Doximity stock in a transaction on Monday, June 8th. The shares were sold at an average price of $20.41, for a total transaction of $49,882.04. Following the completion of the sale, the insider directly owned 90,706 shares of the company’s stock, valued at approximately $1,851,309.46. The trade was a 2.62% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kira Scherer Wampler sold 9,000 shares of the business’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $26.06, for a total transaction of $234,540.00. Following the transaction, the director owned 19,839 shares of the company’s stock, valued at approximately $517,004.34. The trade was a 31.21% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 16,180 shares of company stock valued at $395,110. Corporate insiders own 31.30% of the company’s stock.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. raised its position in shares of Doximity by 99.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 796 shares of the company’s stock worth $35,000 after acquiring an additional 397 shares in the last quarter. Toth Financial Advisory Corp boosted its holdings in Doximity by 100.0% in the fourth quarter. Toth Financial Advisory Corp now owns 1,000 shares of the company’s stock valued at $44,000 after purchasing an additional 500 shares in the last quarter. Advisory Services Network LLC purchased a new position in Doximity in the third quarter valued at approximately $111,000. Farther Finance Advisors LLC raised its holdings in Doximity by 35.7% during the fourth quarter. Farther Finance Advisors LLC now owns 1,539 shares of the company’s stock worth $68,000 after purchasing an additional 405 shares in the last quarter. Finally, Leonteq Securities AG acquired a new stake in Doximity during the fourth quarter worth approximately $78,000. 87.19% of the stock is owned by institutional investors and hedge funds.
About Doximity
Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.
The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.
Featured Articles
- Five stocks we like better than Doximity
- Trip.com’s Selloff Raises a Bigger Question About Its Travel Recovery Story
- Winnebago Misses Estimates, But Surges 14% After Earnings
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
-POPCAT.png){kind=small}
